isomethyleugenol has been researched along with Tuberous Sclerosis in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Douglas-Jones, A; Jiang, WG; Lee-Jones, L; Mansel, RE; Martin, TA; Mokbel, K; Sampson, J; Watkins, G | 1 |
Green, AJ; Sepp, T; Yates, JR | 1 |
2 other study(ies) available for isomethyleugenol and Tuberous Sclerosis
Article | Year |
---|---|
Tuberin and hamartin are aberrantly expressed and linked to clinical outcome in human breast cancer: the role of promoter methylation of TSC genes.
Topics: Breast Neoplasms; Cell Line, Tumor; Female; Humans; Immunohistochemistry; Methylation; Promoter Regions, Genetic; Recurrence; Repressor Proteins; Tuberous Sclerosis; Tuberous Sclerosis Complex 1 Protein; Tuberous Sclerosis Complex 2 Protein; Tumor Suppressor Proteins | 2005 |
Clonality of tuberous sclerosis harmatomas shown by non-random X-chromosome inactivation.
Topics: Angiomyolipoma; Base Sequence; Deoxyribonuclease HpaII; DNA, Neoplasm; Dosage Compensation, Genetic; Exons; Female; Fibroma; Humans; Kidney Neoplasms; Methylation; Molecular Sequence Data; Polymerase Chain Reaction; Polymorphism, Genetic; Receptors, Androgen; Trinucleotide Repeats; Tuberous Sclerosis; X Chromosome | 1996 |